Insmed Inc (INSM)

32.58 +0.08  +0.25% NASDAQ May 7, 20:00 USD
View Full Chart
Price Chart
View All INSM News

News

View All Events

Events

Date Type Description
08/06/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/06/2021 08:30 Earnings Calls Q2 2021 Earnings Call
05/06/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/06/2021 08:30 EDT Earnings Calls Q1 2021 Earnings Call
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/25/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/29/2020 08:30 EDT Earnings Calls Q3 2020 Earnings Call
08/06/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
08/06/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
  • URL: https://www.insmed.com
  • Investor Relations URL: http://investor.insmed.com/index.cfm
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000014EGS ST Healthcare Innovations 8 F RE 5.78%
F0000155EV ST Healthcare Innovations 9 F RE 4.85%
SMHCJX ST Healthcare Innovations 10 RE 3.21%
SBIO ALPS Medical Breakthroughs ETF 2.60%
FRBRX Franklin Biotechnology Discovery R6 1.97%
LAUCX Columbia Acorn USA C 1.48%
LHCQX Lord Abbett Health Care R3 1.40%
IBBJ Defiance Nasdaq Junior Biotechnology ETF 1.04%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.